ClinConnect ClinConnect Logo
Search / Trial NCT06515327

Effects of Corticosteroid Use on Restoration of Spontaneous Circulation in Cardiac Arrest Patients

Launched by SAGLIK BILIMLERI UNIVERSITESI · Jul 17, 2024

Trial Information

Current as of June 27, 2025

Not yet recruiting

Keywords

Cardiac Arrest, Corticosteroids Use,

ClinConnect Summary

This clinical trial is investigating how the use of corticosteroids (a type of medication that can reduce inflammation) before a cardiac arrest affects the ability to restore normal heart function after the event. The researchers want to see if patients who had taken corticosteroids before experiencing a cardiac arrest—whether in a hospital or outside of one—will have a different recovery experience compared to those who did not. They will also look at how these medications influence the need for other drugs used to support heart function after the heart starts beating again.

To participate in this trial, individuals must be at least 18 years old and have experienced a witnessed cardiac arrest. However, those with certain conditions, such as traumatic cardiac arrest or those whose heart did not start beating again after resuscitation efforts lasting over 20 minutes, will not be eligible. The trial is currently not recruiting participants, so no one can join just yet. If you or a loved one meet the eligibility criteria in the future, you may have the opportunity to contribute to important research that could improve care for cardiac arrest patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18 and above Witnessed cardiac arrest
  • Exclusion Criteria:
  • Traumatic cardiac arrest Forensic cases Cardiac arrest secondary to ST-elevation myocardial infarction Patients in whom spontaneous circulation could not be achieved despite cardiopulmonary resuscitation lasting more than 20 minutes Patients with inaccessible past medical records or unknown medication history Patients without identification Unwitnessed cardiac arrest Pregnant patients

About Saglik Bilimleri Universitesi

Saglik Bilimleri Universitesi, or the University of Health Sciences, is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university focuses on translating scientific discoveries into practical applications that enhance patient care and public health outcomes. Its commitment to rigorous ethical standards and comprehensive training equips researchers and healthcare professionals to contribute effectively to the global medical community. Through its clinical trial initiatives, Saglik Bilimleri Universitesi aims to address pressing health challenges and foster the development of new therapeutic strategies.

Locations

Ankara, Yenimahalle, Turkey

Patients applied

0 patients applied

Trial Officials

gulsen akcay, ass. prof.

Study Director

ass. prof. of organization

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported